Intel surge more than 8% after chipmaker’s profits top expectations
LOUISVILLE - BrightSpring Health Services, Inc. (NASDAQ:BTSG) announced Monday that certain stockholders have priced a secondary offering of 15 million shares of common stock. The selling stockholders include an affiliate of Kohlberg Kravis Roberts & Co. L.P. and members of management.
BrightSpring itself is not selling any shares in the offering and will not receive any proceeds. The offering is expected to close on October 22, 2025, subject to customary closing conditions. The company’s stock has shown remarkable strength, trading near its 52-week high of $31.95 with a 90% gain over the past six months, according to InvestingPro data.
The company has also authorized a concurrent purchase of 1.5 million shares from the underwriter at the same price the underwriter will pay to the selling stockholders. This share repurchase is expected to close simultaneously with the offering, though the offering is not contingent on the repurchase being completed.
BofA Securities is serving as the sole book-running manager for the offering. The underwriter plans to offer the shares, except those subject to the share repurchase, through various transactions on the Nasdaq Global Market, in the over-the-counter market, or through negotiated transactions.
The offering is being made under a shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission on June 10, 2025 and became automatically effective upon filing.
BrightSpring Health Services describes itself as a provider of home and community-based health services for complex populations. The information in this article is based on a company press release statement. With analysts maintaining a bullish outlook, investors seeking detailed valuation metrics and 12 additional exclusive insights can access the comprehensive InvestingPro report for BTSG.
In other recent news, BrightSpring Health Services reported a robust third-quarter revenue of approximately $3.33 billion, marking a 28.2% increase from the same period last year. The company also announced a preliminary net income of $37.5 million for the quarter, a significant turnaround from a net loss of $25.7 million in the third quarter of 2024. In light of these results, BrightSpring has raised its full-year guidance for 2025. Additionally, BrightSpring experienced a strong second quarter for 2025, with a 29% year-over-year revenue increase, reaching $3.1 billion. Despite these positive earnings reports, certain stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and members of BrightSpring’s management team, plan to sell 15 million shares in a secondary offering. The company itself will not receive any proceeds from this sale. These developments reflect significant financial and strategic movements within BrightSpring Health Services.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.